WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 576856
Description: MAM2201 N-pentanoic acid metabolite is a potential phase 1 metabolite of MAM2201 -- a cannabinoid receptor agonist.
MedKoo Cat#: 576856
Name: MAM2201 N-pentanoic acid metabolite
Chemical Formula: C25H23NO3
Exact Mass: 385.1678
Molecular Weight: 385.46
Elemental Analysis: C, 77.90; H, 6.01; N, 3.63; O, 12.45
Synonym: JWH 122 N-pentanoic acid metabolite; MAM2201 N-pentanoic acid metabolite
IUPAC/Chemical Name: 5-(3-(4-methyl-1-naphthoyl)-1H-indol-1-yl)pentanoic acid
InChi Key: CXHVTSVFMMQERU-UHFFFAOYSA-N
InChi Code: InChI=1S/C25H23NO3/c1-17-13-14-21(19-9-3-2-8-18(17)19)25(29)22-16-26(15-7-6-12-24(27)28)23-11-5-4-10-20(22)23/h2-5,8-11,13-14,16H,6-7,12,15H2,1H3,(H,27,28)
SMILES Code: O=C(C1=CC=C(C)C2=C1C=CC=C2)C3=CN(CCCCC(O)=O)C4=CC=CC=C43
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 385.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1. Irie T, Kikura-Hanajiri R, Usami M, Uchiyama N, Goda Y, Sekino Y. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors. Neuropharmacology. 2015 Aug;95:479-91. doi: 10.1016/j.neuropharm.2015.02.025. Epub 2015 Mar 5. PMID: 25747605.